LEXINGTON, Mass.--(BUSINESS WIRE)-- Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it has received a Paragraph IV Notice Letter from Hospira, Inc. advising of the filing of an ...

Accord Healthcare is voluntarily recalling 1 lot of Daptomycin for Injection 500mg/vial, and Daptomycin for Injection 350mg/vial to the consumer level due to a product mix-up. According to a product ...

Cubist Pharmaceuticals Issues Voluntary U.S. Recall of Certain Lots of CUBICIN (daptomycin for injection) 500 mg in 10 mL single use vials Due to Presence of Particulate Matter LEXINGTON, ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has introduced Daptomycin for Injection in the United States. Daptomycin for Injection, an antibiotic, is a generic alternative to ...

December 13, 2010 — The US Food and Drug Administration (FDA) has approved a new delivery method for once-daily daptomycin injection (Cubicin; Cubist Pharmaceuticals, Inc), allowing its administration ...

Feb. 6, 2006 — The European Commission has approved daptomycin intravenous infusion for the treatment of complicated skin and soft-tissue infections caused by gram-positive bacteria; Heath Canada has ...

In a 25-minute company presentation, Cubist's President & CEO, Michael W. Bonney, provided an update on the launch of the company's flagship product, Cubicin (TM) (daptomycin for injection), a ...

Methicillin-resistant Staphylococcus Aureus (MRSA) is the most common bacteria which is difficult to treat particularly in children as it may cause complicated skin and skin structure infections. A ...

Dr Reddy’s Laboratories Ltd. today announced the launch of Daptomycin for Injection, 500mg/vial single-dose vial, a therapeutic equivalent generic version of Cubicin for Injection, approved by the US ...

According to Mylan, the administration of the recalled product may lead to “serious adverse events including, but not limited to, local irritation, vasculitis/phlebitis, antigenic or allergic ...

(RTTNews) - Generic and specialty pharma company Mylan N.V. said its U.S.-based business Mylan Institutional LLC recalled one lot of bacterial infection antibiotic Daptomycin in the form of injection ...